NorthRock Partners, LLC

Position in CELC — Celcuity Inc.

CIK 1632097 MINNEAPOLIS, MN

Position in CELC

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$455,515

-$98,406 QoQ

Shares Held

4,354

-10.3% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#177

of 273 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

NorthRock Partners, LLC holds $1,787,469 across 5 Biotechnology names. CELC ranks #2 (25.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,113	$552,860
2	CELC	Celcuity Inc. This page	4,354	$455,515
3	INSM	INSMED Inc	3,082	$328,602
4	TECH	BIO-TECHNE Corp	3,389	$239,432
5	VCEL	Vericel Corp	4,744	$211,060

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$455,515	4,354	-10.3%	Shares	Sole	2026-08-11
2026-03-31	$553,921	4,853	-0.0%	Shares	Sole	2026-05-15
2025-12-31	$484,137	4,854	-18.5%	Shares	Sole	2026-02-17
2025-09-30	$294,127	5,954	—	Shares	Sole	2025-11-14
No filing history on record for this holder in this stock.